Evaluation of the Condition of Rheumatoid Arthritis After Treatment

• Status: Recruiting
• Trial end date: 2025-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Shinshu University
• Collaborator: Showa Inan General Hospital
• Treatments: Tofacitinib

Criteria

Inclusion Criteria:

• Rheumatoid arthritis

Exclusion Criteria:

• Other connective tissue disease